Issues related to development of new antiseizure treatments

Epilepsia

Volumn 54, Issue SUPPL.4, 2013, Pages 24-34

  Wilcox, Karen S ^a   Dixon Salazar, Tracy ^b   Sills, Graeme J ^c   Ben Menachem, Elinor ^d   White, H Steve ^a   Porter, Roger J ^e   Dichter, Marc A ^e   Moshé, Solomon L ^f   Noebels, Jeffrey L ^g   Privitera, Michael D ^h   Rogawski, Michael A ⁱ  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal models of epilepsy; Antiseizure drug; Pharmacoresistant epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; NEW DRUG;

ADULT; ANIMAL; CHILD; DISEASE MODEL; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG SCREENING; FINANCIAL MANAGEMENT; HUMAN; TRANSLATIONAL RESEARCH; ANIMAL MODELS OF EPILEPSY; ANTISEIZURE DRUG; PHARMACORESISTANT EPILEPSY; REVIEW;

ADULT; ANIMALS; ANTICONVULSANTS; CHILD; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; DRUG EVALUATION; DRUG INDUSTRY; DRUGS, INVESTIGATIONAL; HUMANS; RESEARCH SUPPORT AS TOPIC; TRANSLATIONAL MEDICAL RESEARCH;

ANIMAL MODELS OF EPILEPSY; ANTISEIZURE DRUG; PHARMACORESISTANT EPILEPSY;

EID: 84891676185     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12296     Document Type: Article

References (70)

1. Albus K, Wahab A, Heinemann U. (2008) Standard antiepileptic drugs fail to block epileptiform activity in rat organotypic hippocampal slice cultures. Br J Pharmacol 154:709-724.
2. Arroyo S, Perucca E. (2003) Translating monotherapy trials into clinical practice: a look into the abyss. Epilepsy Behav 4:457-463.
3. Bankstahl M, Bankstahl JP, Loscher W. (2012) Inter-individual variation in the anticonvulsant effect of phenobarbital in the pilocarpine rat model of temporal lobe epilepsy. Exp Neurol 234:70-84.
4. Barton ME, Klein BD, Wolf HH, White HS. (2001) Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res 47:217-227.
5. Bethmann K, Brandt C, Loscher W. (2007) Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy. Epilepsia 48:816-826.
6. Bialer M. (2012) Comments on the working group's 2012 review of the Program. Epilepsia 53:1844-1846.
7. Bolkvadze T, Pitkanen A. (2012) Development of post-traumatic epilepsy after controlled cortical impact and lateral fluid-percussioninduced brain injury in the mouse. J Neurotrauma 29:789-812.
8. Brown WC, Schiffman DO, Swinyard EA, Goodman LS. (1953) Comparative assay of an antiepileptic drugs by psychomotor seizure test and minimal electroshock threshold test. J Pharmacol Exp Ther 107:273-283.
9. Byrtus H, Obniska J, Czopek A, Kaminski K. (2011) Synthesis and anticonvulsant activity of new n-mannich bases derived from 5-cyclopropyl-5- phenyl-hydantoins. Arch Pharm (Weinheim) 344:231-241.
10. Chege SW, Hortopan GA, Dinday M, Baraban SC. (2012) Expression and function of KCNQ channels in larval zebrafish. Dev Neurobiol 72:186-198.
11. Coppola A, Moshe SL. (2009) Why is the developing brain more susceptible to status epilepticus? Epilepsia 50(Suppl. 12):25-26.
12. Coppola A, Moshe SL. (2012) Animal models. Handb Clin Neurol 107:63-98.
13. Cramer S, Ebert U, Loscher W. (1998) Characterization of phenytoinresistant kindled rats, a new model of drug-resistant partial epilepsy: comparison of inbred strains. Epilepsia 39:1046-1053.
14. D'Ambrosio R, Hakimian S, Stewart T, Verley DR, Fender JS, Eastman CL, Sheerin AH, Gupta P, Diaz-Arrastia R, Ojemann J, Miller JW. (2009) Functional definition of seizure provides new insight into post-traumatic epileptogenesis. Brain 132:2805-2821.
15. Dyhrfjeld-Johnsen J, Berdichevsky Y, Swiercz W, Sabolek H, Staley KJ. (2010) Interictal spikes precede ictal discharges in an organotypic hippocampal slice culture model of epileptogenesis. J Clin Neurophysiol 27:418-424.
16. Eastman CL, Verley DR, Fender JS, Temkin NR, D'Ambrosio R. (2010) ECoG studies of valproate, carbamazepine and halothane in frontal-lobe epilepsy induced by head injury in the rat. Exp Neurol 224:369-388.
17. Eastman CL, Verley DR, Fender JS, Stewart TH, Nov. E, Curia G, D'Ambrosio R. (2011) Antiepileptic and antiepileptogenic performance of carisbamate after head injury in the rat: blind and randomized studies. J Pharmacol Exp Ther 336:779-790.
18. Ebert U, Rundfeldt C, Lehmann H, Loscher W. (1999) Characterization of phenytoin-resistant kindled rats, a new model of drug-resistant partial epilepsy: influence of experimental and environmental factors. Epilepsy Res 33:199-215.
19. Ebert U, Reissmuller E, Loscher W. (2000) The new antiepileptic drugs lamotrigine and felbamate are effective in phenytoin-resistant kindled rats. Neuropharmacology 39:1893-1903.
20. Engel J, Pitkanen A, Loeb JA, Dudek FE, Bertram E H I, Cole AJ, Moshe SL, Wiebe S, Fureman BE, Jensen F, Mody I, Nehlig A, Vezzani A. (2013) Epilepsy biomarkers. Epilepsia 54:61-69.
21. England MJ, Liverman CT, Schultz AM, Strawbridge LM. (2012) Epilepsy across the spectrum: promoting health and understanding. National Academies Press, Washington, DC.
22. French J. (2012) The value of blind screening in the Anticonvulsant Screening Program. Epilepsia 53:1842-1843.
23. French JA, Temkin NR, Shneker BF, Hammer AE, Caldwell PT, Messenheimer JA. (2012) Lamotrigine XR conversion to monotherapy: first study using a historical control group. Neurotherapeutics 9:176-184.
24. Galanopoulou AS. (2013) Basic mechanisms of catastrophic epilepsy - overview from animal models. Brain Dev Jan 10 [Epub ahead of print].
25. Gasior M, Yankura J, Hartman AL, French A, Rogawski MA. (2010) Anticonvulsant and proconvulsant actions of 2-deoxy-D-glucose. Epilepsia 51:1385-1394.
26. Glien M, Brandt C, Potschka H, Loscher W. (2002) Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy. Epilepsia 43:350-357.
27. Grabenstatter HL, Ferraro DJ, Williams PA, Chapman PL, Dudek FE. (2005) Use of chronic epilepsy models in antiepileptic drug discovery: the effect of topiramate on spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsia 46:8-14.
28. Grabenstatter HL, Clark S, Dudek FE. (2007) Anticonvulsant effects of carbamazepine on spontaneous seizures in rats with kainate-induced epilepsy: comparison of intraperitoneal injections with drug-in-food protocols. Epilepsia 48:2287-2295.
29. Hasson H, Kim M, Moshe SL. (2008) Effective treatments of prolonged status epilepticus in developing rats. Epilepsy Behav 13:62-69.
30. Jandova K, Pasler D, Antonio LL, Raue C, Ji S, Njunting M, Kann O, Kovacs R, Meencke HJ, Cavalheiro EA, Heinemann U, Gabriel S, Lehmann TN. (2006) Carbamazepine-resistance in the epileptic dentate gyrus of human hippocampal slices. Brain 129:3290-3306.
31. Kaminski K, Rzepka S, Obniska J. (2011) Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl) ethyl] pyrrolidine-2, 5-diones. Bioorg Med Chem Lett 21:5800-5803.
32. Kharatishvili I, Pitkanen A. (2010) Association of the severity of cortical damage with the occurrence of spontaneous seizures and hyperexcitability in an animal model of posttraumatic epilepsy. Epilepsy Res 90:47-59.
33. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshe SL, Perucca E, Wiebe S, French J. (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51:1069-1077.
34. Langlois M, Bouyssieres C, Duveau V, Dumont C, Roucard C. (2012) Improving the development of promising drug candidates: preclinical solutions developed in chronic models of epilepsy. Annual Meeting of the American Epilepsy Society, San Diego, CA.
35. Lee CL, Frost JD Jr, Swann JW, Hrachovy RA. (2008) A new animal model of infantile spasms with unprovoked persistent seizures. Epilepsia 49:298-307.
36. Leite JP, Cavalheiro EA. (1995) Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats. Epilepsy Res 20:93-104.
37. Loscher W, Rundfeldt C, Honack D. (1993) Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy. Epilepsy Res 15:207-219.
38. Loscher W, Reissmuller E, Ebert U. (2000) Anticonvulsant efficacy of gabapentin and levetiracetam in phenytoin-resistant kindled rats. Epilepsy Res 40:63-77.
39. Maroso M, Balosso S, Ravizza T, Iori V, Wright CI, French J, Vezzani A. (2011) Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 8:304-315.
40. Moshé SL, Ludvig N. (1988) Kindling. In Pedley TA, Meldrum BS (Eds) Recent advances in epilepsy. Churchill Livingtone, Oxford, pp. 21-44.
41. Nehlig A. (2012) Syndromes, animal models, and brain development. In Bureau M, Genton P, Dravet C, Delgado-Escueta AV, Tassinari CA, Thomas P, Wolf P (Eds) Epileptic syndromes in infancy, childhood and adolescence. John Libbey Eurotext Ltd, Montrouge, France, pp. 43-58.
42. Noam Y, Raol YH, Holmes GL. (2013) Searching for new targets for treatment of pediatric epilepsy. Epilepsy Behav 26:253-260.
43. Oakley JC, Cho A, Cheah CS, Scheuer T, Catterall WA. (2013) Synergistic GABA-enhancing therapy against seizures in a mouse model of Dravet syndrome. J Pharmacol Exp Ther 345:215-224.
44. Perucca P, Gilliam FG (2012) Adverse effects of antiepileptic drugs. Lancet Neurol 11:792-802.
45. Postma T, Krupp E, Li XL, Post RM, Weiss SR. (2000) Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy. Epilepsia 41:1514-1521.
46. Price MG, Yoo JW, Burgess DL, Deng F, Hrachovy RA, Frost JD Jr, Noebels JL. (2009) A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx (GCG) 10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment. JNeurosci 29:8752-8763.
47. Ranganathan R. (2012) The response of NINDS to recommendations from the working group's 2012 review of the Program. Epilepsia 53:1839-1840.
48. Rattka M, Brandt C, Loscher W. (2013) The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats. Epilepsy Res 103:135-152.
49. Ravizza T, Lucas SM, Balosso S, Bernardino L, Ku G, Noe F, Malva J, Randle JC, Allan S, Vezzani A. (2006) Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia 47:1160-1168.
50. Reissmuller E, Ebert U, Loscher W. (2000) Anticonvulsant efficacy of topiramate in phenytoin-resistant kindled rats. Epilepsia 41:372-379.
51. Remy S, Gabriel S, Urban BW, Dietrich D, Lehmann TN, Elger CE, Heinemann U, Beck H. (2003) A novel mechanism underlying drug resistance in chronic epilepsy. Ann Neurol 53:469-479.
52. Riban V, Bouilleret V, Pham-Le BT, Fritschy JM, Marescaux C, Depaulis A. (2002) Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neuroscience 112:101-111.
53. Rowley NM, White HS. (2010) Comparative anticonvulsant efficacy in the corneal kindled mouse model of partial epilepsy: correlation with other seizure and epilepsy models. Epilepsy Res 92:163-169.
54. Scantlebury MH, Galanopoulou AS, Chudomelova L, Raffo E, Betancourth D, Moshe SL. (2010) A model of symptomatic infantile spasms syndrome. Neurobiol Dis 37:604-612.
55. Schmidt D, Loscher W. (2009) New developments in antiepileptic drug resistance: an integrative view. Epilepsy Curr 9:47-52.
56. Schmidt D, Sillanpaa M. (2012) Evidence-based review on the natural history of the epilepsies. Curr Opin Neurol 25:159-163.
57. Shinnar S, Glauser T. (2012) Commentary on Anticonvulsant Screening Program update: children are not little adults. Epilepsia 53:1843-1844.
58. Singh NA, Otto JF, Dahle EJ, Pappas C, Leslie JD, Vilaythong A, Noebels JL, White HS, Wilcox KS, Leppert MF. (2008) Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization. J Physiol 586:3405-3423.
59. Smith MD, Adams AC, Saunders GW, White HS, Wilcox KS. (2007) Phenytoin- and carbamazepine-resistant spontaneous bursting in rat entorhinal cortex is blocked by retigabine in vitro. Epilepsy Res 74:97-106.
60. Srivastava AK, White HS. (2013) Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats. Epilepsy Res 104:26-34.
61. Stables JP, Bertram E, Dudek FE, Holmes G, Mathern G, Pitkanen A, White HS. (2003) Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop. Epilepsia 44:1472-1478.
62. Szoeke CE, Newton M, Wood JM, Goldstein D, Berkovic SF, Tj OB, Sheffield LJ. (2006) Update on pharmacogenetics in epilepsy: a brief review. Lancet Neurol 5:189-196.
63. Velisek L, Veliskova J, Ptachewich Y, Ortiz J, Shinnar S, Moshe SL. (1995a) Age-dependent effects of gamma-aminobutyric acid agents on flurothyl seizures. Epilepsia 36:636-643.
64. Velisek L, Veliskova J, Ptachewich Y, Shinnar S, Moshe SL. (1995b) Effects of MK-801 and phenytoin on flurothyl-induced seizures during development. Epilepsia 36:179-185.
65. Wahab A, Albus K, Gabriel S, Heinemann U. (2010a) In search of models of pharmacoresistant epilepsy. Epilepsia 51(Suppl. 3):154-159.
66. Wahab A, Albus K, Heinemann U. (2010b) Drug refractoriness of epileptiform activity in organotypic hippocampal slice cultures depends on the mode of provocation. Epilepsy Res 90:304-308.
67. Williams PA, White AM, Clark S, Ferraro DJ, Swiercz W, Staley KJ, Dudek FE. (2009) Development of spontaneous recurrent seizures after kainate-induced status epilepticus. J Neurosci 29:2103-2112.
68. Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F, Burton KA, Spain WJ, McKnight GS, Scheuer T, Catterall WA. (2006) Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 9:1142-1149.
69. Zhang CL, Dreier JP, Heinemann U. (1995) Paroxysmal epileptiform discharges in temporal lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants. Epilepsy Res 20:105-111.
70. Zhang B, McDaniel S, Rensing NR, Wong M. (2013) Vigabatrin Inhibits Seizures and mTOR Pathway Activation in a Mouse Model of Tuberous Sclerosis Complex. PLoS One 8(2):e57445.